IL-2 turned on the list of first candidates for most cancers immunotherapy following its discovery like a essential variable for T cell functioning [1]. CD8+ T cells are an integral part of the adaptive immune program and are very important for recognizing and eradicating virally contaminated and malignant cells. As a result, the ability to create